Enveric Biosciences Inc. (ENVB)
NASDAQ: ENVB
· Real-Time Price · USD
1.01
-0.04 (-3.81%)
At close: Sep 04, 2025, 3:59 PM
0.94
-6.97%
After-hours: Sep 04, 2025, 07:22 PM EDT
-3.81% (1D)
| Bid | 1 |
| Market Cap | 2.5M |
| Revenue (ttm) | 340.38K |
| Net Income (ttm) | -9.94M |
| EPS (ttm) | -9.97 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | -0.04 |
| Analyst | Buy |
| Ask | 1.09 |
| Volume | 126,363 |
| Avg. Volume (20D) | 214,020 |
| Open | 1.04 |
| Previous Close | 1.05 |
| Day's Range | 1.00 - 1.05 |
| 52-Week Range | 1.00 - 126.00 |
| Beta | 0.37 |
About ENVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENVB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENVB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+8.2%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
6 months ago
+94.92%
Enveric Biosciences shares are trading higher after the company announced its non-hallucinogenic psychedelic compounds showed promise for treating addiction and ADHD.
2 months ago · businesswire.com
Enveric Biosciences Announces Participation in 2025 BIO International ConventionCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therap...
